Markets InsiderSynthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of ResearchMarkets InsiderSAN DIEGO, Aug. 14, 2017 /PRNewswire/ — Synthorx Inc., a biotechnology company using synthetic biology to discover and develop novel protein therap… Continue reading
PR Newswire (press release)Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of ResearchPR Newswire (press release)SAN DIEGO, Aug. 14, 2017 /PRNewswire/ — Synthorx Inc., a biotechnology company using synthetic biology to discover and deve… Continue reading
pharmaphorum |
Real world data essential for CAR–T therapy success
pharmaphorum Novartis looks like it will get its chimeric antigen receptor T–cell (CAR-T) therapy to market ahead of rival Kite in blood cancer. The therapy involves harvesting a patient’s own T–cells and genetically modifying them to attack cancer – a process that … |
|
Stem cell therapy may help knees
Citizens Voice Q: I read that you can use your own stem cells to rejuvenate worn-out knees. Does this really work? A: “Worn out” is a good way to term what happens to the knee joint with prolonged use. Let’s look at how this happens, starting with cartilage. The … |
Big Think |
Scientists Use CRISPR Gene Editing to Create the World’s First Mutant Social Insect
Big Think The team from Rockefeller University published a paper outlining how they removed orco – a gene that plays a key part in an ant’s odor receptors. Deleting the gene by using the CRISPR-Cas9 technique resulted in the ants losing about 90% of their … Scientists create world’s first mutant ants with gene editing technologyNEWS.com.au |